Glen Allen, VA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-device combinations and auto-injector innovation, recognizes its 25th anniversary by celebrating the people, purpose, ...

Auto-injectors are pre-filled, single-use, self-contained drug delivery systems that allow the user to self-administer precise dosages of injectable medication quickly and easily, without the ...

Phillips-Medisize, in collaboration with its customer, Ascendis Pharma, was recently recognized with a third industry award for the Skytrofa Auto-Injector. The Red Dot Award recognizes the drug ...

TOKYO--(BUSINESS WIRE)--SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, announced today that SHL Marketing Director Steven Kaufman will ...

My son Thomas has carried around a needle since he entered kindergarten at the age of 5. That was a big responsibility for a small child to carry an injector loaded with lifesaving epinephrine, but ...

- Supply agreement supports Viridian’s development of potential first- and best-in-class subcutaneous therapies for treatment of thyroid eye disease (TED) - - Ypsomed brings strong track record of ...

The cost of epinephrine auto-injector devices, commonly known as "EpiPen" devices, is slated to become a little more affordable for families due to legislation recently signed into law in New York.

Instron’s CT6 can be configured as an automated solution for the required testing of auto-injection devices – providing the benefits of automation without the additional complexity of a fully ...

Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...

With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare ...